Searched for
GENERIC CHRONIC CONSTIPATION TREATMENT
Over 44.73 crore Ayushman cards generated under AB-PMJAY: GovtOver 44.73 crore Ayushman cards have been created under the national health scheme. More than 12.69 crore hospital admissions were authoriz...- Alembic Pharma gets USFDA approval for generic chronic constipation treatment tabletsAlembic Pharmaceuticals announced USFDA approval for its generic prucalopride tablets. The company received final approval for strengths of...
- You’re So Vain’ singer Carly Simon reveals Parkinson’s disease diagnosis: Symptoms, treatment and whether there is a cureCarly Simon Parkinson’s disease news: Grammy-winning singer-songwriter Carly Simon has revealed that she has been diagnosed with Parkinson’...
- In 2007, a last-resort cancer treatment led to an extraordinary HIV breakthrough that helped rewrite medical historyCancer treatment received major breakthrough in 2007 and the findings remain one of the most remarkable chapters in modern medicine. A trea...
- Tariff on generic drugs: Loud announcement, little consequence? 7 pharma stocks with upside potential of up to 31%The threat of a US tariff on Indian pharma is no longer a vague fear; or at least that is what President Trump wants us to believe. There i...
- US market drag keeps Dr Reddy's, Cipla under pressure despite strong product pipelineIndian pharmaceutical firms experienced a challenging June quarter, marked by declining US business profits. Dr Reddy's and Cipla saw signi...
- US tariff proposal wake-up call for Indian pharma to diversify, innovate: ExpertsUS pharma tariffs: Experts have urged a shift towards global diversification and prioritising innovation for Indian pharma to lessen market...
- Cipla expects sequential recovery in North America on new product launches despite tariff uncertaintyCipla reported a 39% drop in net profit to ₹789 crore for the June quarter due to weakness in its North America business and margin compres...
- Dr Reddy’s aims to resume semaglutide supply by November after API fixDr Reddy's expects to resume semaglutide supplies by November after resolving quality issues. The company identified the root cause and pla...
- Domestic formulations, chronic therapies to drive Pharma Q1; US generics remain dragThe healthcare sector anticipates strong growth in domestic formulations and emerging markets. Companies with less US generics dependence w...
- Generic drugmaker Sandoz to engage with US after Trump tariff threatUS President Donald Trump threatened steep tariffs on generic drugmakers. He stated medicines must be manufactured locally or face signific...
- Indian pharma firms may yet survive Trump's 200% tariff bombshellDonald Trump's proposed up to 200% tariff on generic drug imports has raised concerns for Indian pharma companies, but industry experts say...
- Legionnaires' disease outbreak in NYC kills 5: How dangerous Legionella bacteria multiply in ACs and cooling towers, symptoms, prevention and treatment explainedLegionnaires disease outbreak: New York City is experiencing a Legionnaires' disease outbreak with five fatalities reported. Health officia...
- Trump’s 100% generic drug duty threatens US low-cost supplyPresident Donald Trump has given generic drugmakers two years to shift manufacturing to the US or face 100% import tariffs from August 2028...
- Forget detox drinks. Harvard-trained gastroenterologist Dr Saurabh Sethi shares 3 simple habits that naturally improve gut healthTrue wellness relies on sustainable lifestyle habits, not quick fixes. As per Harvard-trained gastroenterologist Dr Saurabh Sethi, prioriti...
- Emcure Pharma gets CDSCO nod to market Poviztra for fatty liver treatmentEmcure Pharmaceuticals announced its brand Poviztra is now available for fatty liver treatment. This follows regulatory approval for treati...
- Alembic Pharma partner NATCO gets USFDA tentative nod for generic Olaparib tablets; US market size at USD 1.4 bnAlembic Pharmaceuticals and NATCO Pharma received tentative USFDA approval for generic Olaparib tablets. This approval is for a cancer drug...
- Indiana Jones star Harrison Ford goes viral for his muscles. 83-year-old superstar once revealed ‘boring’ secret to his fitness. Research says, it can lower risk of cancer and heart attackHollywood veteran Harrison Ford’s pictures of accidentally showing off his muscles and toned body went viral. Fans were in awe of his impec...
- Novo Nordisk's obesity drug Wegovy wins India approval to fight silent fatty liver killerIndia's drug regulator approved Novo Nordisk's Wegovy for MASH treatment. This drug targets a serious progressive form of fatty liver disea...
- Sun Pharma gets SAHPRA approval for generic semaglutide injection in South Africa for type 2 diabetesSouth Africa's regulator approved Sun Pharma's generic semaglutide injection for diabetes. This approval allows marketing to supplement die...
Load More
